News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Langermann Sol
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/01/2023 |
4
| Langermann Sol (Chief Scientific Officer) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 135,000 options to buy
@ $1.55, valued at
$209.3k
|
|
| 02/02/2022 |
4
| Langermann Sol (Chief Scientific Officer) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 117,400 options to buy
@ $5.57, valued at
$653.9k
|
|
| 03/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Langermann Sol (Chief Scientific Officer) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 78,200 options to buy
@ $41.76, valued at
$3.3M
|
|
| 05/08/2019 |
3
| Langermann Sol (Chief Scientific Officer) has filed a Form 3 on NextCure, Inc. |
|
|